Newsroom

A mix of healthy red blood cells and misshapen cells caused by sickle cell disease. These sickle-shaped cells can clog arteries, producing a range of serious health effects.
Three young siblings don UCLA gear.
Headshot of Donald Kohn in the lab
Sickle Cell clinical trial patient Evie Junior
Headshot of S. Thomas Carmichael on left, headshot of Donald Kohn on right
A section of an artificial thymic organoid showing T cells (outlined in green) created from blood stem cells. | UCLA Broad Stem Cell Research Center/Cell Reports
Family photo: Christian and Alysia Padilla-Vaccaro with daughters Gigi (left), Annabella (seated) and Evangelina. Evangelina was born with a rare genetic immunodeficiency disorder, but thanks to a novel gene therapy at UCLA, her immune system was restored.
Photograph of Brenden Whittaker
At left, image shows white blood cells (red) from one of the X-CGD clinical trial participants before gene therapy. At right, after gene therapy, white blood cells from the same patient show the presence of the chemicals (blue) needed to attack and destroy bacteria and fungus.